Login / Signup

Nme 2 Cas9-mediated therapeutic editing in inhibiting angiogenesis after wet age-related macular degeneration onset.

Sihui HuYuxi ChenDongchun XieKan XuYunzhao FuWei ChiHaiying LiuJunjiu Huang
Published in: Clinical and translational medicine (2023)
Cas9 for potential anti-angiogenesis therapy in wet AMD.
Keyphrases
  • age related macular degeneration
  • crispr cas
  • genome editing
  • endothelial cells
  • vascular endothelial growth factor
  • wound healing
  • signaling pathway
  • human health
  • mesenchymal stem cells
  • climate change